Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VISX -- Ignore unavailable to you. Want to Upgrade?

To: Charlie Smith who wrote (614)	6/29/1998 4:24:00 PM
From: Jim Mac	Respond to of 1754

SBC Warburg has been wrong for a year now. I don't expect them to be correct all of a sudden. For a long time, they thought LVCI would lose $0.48 in FY98 (April), and earn $0.02 in FY99. They were way off. JulyQ looks closer to $0.10 than $0.04. And FY00/CY99 looks closer to $1.00 (fully-taxed), $1.50 on cash earnings basis. AG Edwards has been on the money: ($0.40) FY98, $0.71 FY00. Just look at how Visx analysts severely underestimated 1998. Visx won't earn merely $1.28 as was believed last year. Visx will earn over $2.00. LVCI should surprise too. Although I wish they'd start acquiring more practices or something. LZRCF is looking more and more like the market dominator LVCI professed it would be.